Work Here?
Work Here?
Work Here?
Adaptive Biotechnologies focuses on using the immune system to improve disease diagnosis and treatment. The company decodes genetic information from immune cell receptors, which are essential for the immune system's ability to identify and respond to diseases. One of their key projects is the ImmuneRACE study, which analyzes blood samples and swabs from participants to understand how the immune system reacts to COVID-19. This research aims to enhance diagnostics, treatments, and vaccines for the virus. Adaptive Biotechnologies uses advanced data algorithms to analyze immune cell genetics and generates revenue through partnerships with pharmaceutical companies, licensing technology, and offering diagnostic services. Their goal is to leverage immune system data to advance healthcare and address various diseases.
Company Stage
IPO
Employees
501-1,000
Industries
Data & Analytics, Biotechnology, Healthcare
Total Funding
$395.8M
Headquarters
N/A
Founded
2009
Help us improve and share your feedback! Did you find this helpful?
Find jobs on Simplify and start your career today